Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RedBird Capital Partners is a private equity firm that manages over $10 billion in assets across several core industry verticals, including Healthcare, Sports, Media, and Financial Services. In the healthcare sector, RedBird focuses on investing in and building platforms within healthcare services, technology-enabled solutions, and advanced diagnostics. The firm's investment strategy emphasizes partnering with founders and entrepreneurs to scale businesses through operational expertise and long-term capital. Key healthcare portfolio companies include Compass Surgical Partners, a leader in ambulatory surgery center management, and PreciseDx, an AI-driven oncology diagnostics company. RedBird typically targets companies that are at an inflection point of growth and provides them with strategic and financial resources to expand their market presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RedBird Capital Partners.